United States · FDA National Drug Code directory
tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-776_2cee3817-e6f6-9db6-e063-6294a90a6ea1
- Product NDC
- 71610-776
- Form
- TABLET
- Composition / generic term
- tizanidine
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040116
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6000 TABLET in 1 BOTTLE (71610-776-16) · 71610-776-16
- 30 TABLET in 1 BOTTLE (71610-776-30) · 71610-776-30
- 60 TABLET in 1 BOTTLE (71610-776-53) · 71610-776-53
- 90 TABLET in 1 BOTTLE (71610-776-60) · 71610-776-60
- 120 TABLET in 1 BOTTLE (71610-776-70) · 71610-776-70
- 7500 TABLET in 1 BOTTLE (71610-776-75) · 71610-776-75
- 180 TABLET in 1 BOTTLE (71610-776-80) · 71610-776-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →